Submucosal Injections - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511242772

Publication Date:

November 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The submucosal injections are required principally during the endoscopic mucosal resection techniques.They are an indispensable part of endoscopic submucosal dissection.听The most common submucosal injections were glucose water, hydroxypropyl methyl cellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.
The global market for Submucosal Injections was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Submucosal injection is commonly used in medical and surgical procedures to achieve diagnosis, treatment, or relief. The increase in the incidence rate of cancer, the surge in the number of endoscopic mucosal resection, the increase in favorable reimbursement policies, and the development of the healthcare sector are the main drivers of global market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Submucosal Injections, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Submucosal Injections by region & country, by Type, and by Application.
The Submucosal Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injections.
Market Segmentation
By Company
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus
Segment by Type:
Syringe Type
Ampoules Type
Segment by Application
Hospital
Outpatient Surgery Center
Specialized Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Submucosal Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Submucosal Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Submucosal Injections in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Submucosal Injections Product Introduction
1.2 Global Submucosal Injections Market Size Forecast
1.2.1 Global Submucosal Injections Sales Value (2019-2030)
1.2.2 Global Submucosal Injections Sales Volume (2019-2030)
1.2.3 Global Submucosal Injections Sales Price (2019-2030)
1.3 Submucosal Injections Market Trends & Drivers
1.3.1 Submucosal Injections Industry Trends
1.3.2 Submucosal Injections Market Drivers & Opportunity
1.3.3 Submucosal Injections Market Challenges
1.3.4 Submucosal Injections Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Submucosal Injections Players Revenue Ranking (2023)
2.2 Global Submucosal Injections Revenue by Company (2019-2024)
2.3 Global Submucosal Injections Players Sales Volume Ranking (2023)
2.4 Global Submucosal Injections Sales Volume by Company Players (2019-2024)
2.5 Global Submucosal Injections Average Price by Company (2019-2024)
2.6 Key Manufacturers Submucosal Injections Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Submucosal Injections Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Submucosal Injections
2.9 Submucosal Injections Market Competitive Analysis
2.9.1 Submucosal Injections Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Submucosal Injections Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Submucosal Injections as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Syringe Type
3.1.2 Ampoules Type
3.2 Global Submucosal Injections Sales Value by Type
3.2.1 Global Submucosal Injections Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Submucosal Injections Sales Value, by Type (2019-2030)
3.2.3 Global Submucosal Injections Sales Value, by Type (%) (2019-2030)
3.3 Global Submucosal Injections Sales Volume by Type
3.3.1 Global Submucosal Injections Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Submucosal Injections Sales Volume, by Type (2019-2030)
3.3.3 Global Submucosal Injections Sales Volume, by Type (%) (2019-2030)
3.4 Global Submucosal Injections Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Outpatient Surgery Center
4.1.3 Specialized Clinics
4.2 Global Submucosal Injections Sales Value by Application
4.2.1 Global Submucosal Injections Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Submucosal Injections Sales Value, by Application (2019-2030)
4.2.3 Global Submucosal Injections Sales Value, by Application (%) (2019-2030)
4.3 Global Submucosal Injections Sales Volume by Application
4.3.1 Global Submucosal Injections Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Submucosal Injections Sales Volume, by Application (2019-2030)
4.3.3 Global Submucosal Injections Sales Volume, by Application (%) (2019-2030)
4.4 Global Submucosal Injections Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Submucosal Injections Sales Value by Region
5.1.1 Global Submucosal Injections Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Submucosal Injections Sales Value by Region (2019-2024)
5.1.3 Global Submucosal Injections Sales Value by Region (2025-2030)
5.1.4 Global Submucosal Injections Sales Value by Region (%), (2019-2030)
5.2 Global Submucosal Injections Sales Volume by Region
5.2.1 Global Submucosal Injections Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Submucosal Injections Sales Volume by Region (2019-2024)
5.2.3 Global Submucosal Injections Sales Volume by Region (2025-2030)
5.2.4 Global Submucosal Injections Sales Volume by Region (%), (2019-2030)
5.3 Global Submucosal Injections Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Submucosal Injections Sales Value, 2019-2030
5.4.2 North America Submucosal Injections Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Submucosal Injections Sales Value, 2019-2030
5.5.2 Europe Submucosal Injections Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Submucosal Injections Sales Value, 2019-2030
5.6.2 Asia Pacific Submucosal Injections Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Submucosal Injections Sales Value, 2019-2030
5.7.2 South America Submucosal Injections Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Submucosal Injections Sales Value, 2019-2030
5.8.2 Middle East & Africa Submucosal Injections Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Submucosal Injections Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Submucosal Injections Sales Value
6.2.1 Key Countries/Regions Submucosal Injections Sales Value, 2019-2030
6.2.2 Key Countries/Regions Submucosal Injections Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Submucosal Injections Sales Value, 2019-2030
6.3.2 United States Submucosal Injections Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Submucosal Injections Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Submucosal Injections Sales Value, 2019-2030
6.4.2 Europe Submucosal Injections Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Submucosal Injections Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Submucosal Injections Sales Value, 2019-2030
6.5.2 China Submucosal Injections Sales Value by Type (%), 2023 VS 2030
6.5.3 China Submucosal Injections Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Submucosal Injections Sales Value, 2019-2030
6.6.2 Japan Submucosal Injections Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Submucosal Injections Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Submucosal Injections Sales Value, 2019-2030
6.7.2 South Korea Submucosal Injections Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Submucosal Injections Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Submucosal Injections Sales Value, 2019-2030
6.8.2 Southeast Asia Submucosal Injections Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Submucosal Injections Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Submucosal Injections Sales Value, 2019-2030
6.9.2 India Submucosal Injections Sales Value by Type (%), 2023 VS 2030
6.9.3 India Submucosal Injections Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Seikagaku
7.1.1 Seikagaku Company Information
7.1.2 Seikagaku Introduction and Business Overview
7.1.3 Seikagaku Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Seikagaku Submucosal Injections Product Offerings
7.1.5 Seikagaku Recent Development
7.2 Ovesco Endoscopy
7.2.1 Ovesco Endoscopy Company Information
7.2.2 Ovesco Endoscopy Introduction and Business Overview
7.2.3 Ovesco Endoscopy Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Ovesco Endoscopy Submucosal Injections Product Offerings
7.2.5 Ovesco Endoscopy Recent Development
7.3 GI Supply
7.3.1 GI Supply Company Information
7.3.2 GI Supply Introduction and Business Overview
7.3.3 GI Supply Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.3.4 GI Supply Submucosal Injections Product Offerings
7.3.5 GI Supply Recent Development
7.4 Cosmo Pharmaceuticals
7.4.1 Cosmo Pharmaceuticals Company Information
7.4.2 Cosmo Pharmaceuticals Introduction and Business Overview
7.4.3 Cosmo Pharmaceuticals Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cosmo Pharmaceuticals Submucosal Injections Product Offerings
7.4.5 Cosmo Pharmaceuticals Recent Development
7.5 Boston Scientific
7.5.1 Boston Scientific Company Information
7.5.2 Boston Scientific Introduction and Business Overview
7.5.3 Boston Scientific Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Boston Scientific Submucosal Injections Product Offerings
7.5.5 Boston Scientific Recent Development
7.6 The Standard
7.6.1 The Standard Company Information
7.6.2 The Standard Introduction and Business Overview
7.6.3 The Standard Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.6.4 The Standard Submucosal Injections Product Offerings
7.6.5 The Standard Recent Development
7.7 Micro-Tech Endoscopy
7.7.1 Micro-Tech Endoscopy Company Information
7.7.2 Micro-Tech Endoscopy Introduction and Business Overview
7.7.3 Micro-Tech Endoscopy Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Micro-Tech Endoscopy Submucosal Injections Product Offerings
7.7.5 Micro-Tech Endoscopy Recent Development
7.8 EndoClot Plus
7.8.1 EndoClot Plus Company Information
7.8.2 EndoClot Plus Introduction and Business Overview
7.8.3 EndoClot Plus Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
7.8.4 EndoClot Plus Submucosal Injections Product Offerings
7.8.5 EndoClot Plus Recent Development
8 Industry Chain Analysis
8.1 Submucosal Injections Industrial Chain
8.2 Submucosal Injections Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Submucosal Injections Sales Model
8.5.2 Sales Channel
8.5.3 Submucosal Injections Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂